Histone lysine trimethylation or acetylation can be modulated by phytoestrogen, estrogen or anti-HDAC in breast cancer cell lines

Epigenomics

Volumn 5, Issue 1, 2013, Pages 51-63

  Dagdemir, Aslihan ^a,b,c   Durif, Julie ^a,b,c   Ngollo, Marjolaine ^a,b,c   Bignon, Yves Jean ^a,b,c   Bernard Gallon, Dominique ^a,b,c  

^a CENTRE JEAN PERRIN   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c CRNH AUVERGNE   (France)

Author keywords

acetylation; breast cancer; histone; methylation; soy phytoestrogens

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; DAIDZEIN; EQUOL; ESTRADIOL; ESTROGEN; GENISTEIN; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; HISTONE H4; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; VORINOSTAT;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; EPIGENETICS; HISTONE ACETYLATION; HUMAN; HUMAN CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ACETYLATION; BREAST NEOPLASMS; CHROMATIN; DNA METHYLATION; EPIGENESIS, GENETIC; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE INHIBITORS; HISTONE DEMETHYLASES; HISTONES; HUMANS; LYSINE; MCF-7 CELLS; PHYTOESTROGENS; SOYBEANS;

EID: 84874033876     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.12.74     Document Type: Article

References (46)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 61(2), 69-90 (2011).
2. Kuiper GG, Lemmen JG, Carlsson B et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139(10), 4252-4263 (1998).
3. Pfitscher A, Reiter E, Jungbauer A. Receptor binding and transactivation activities of red clover isoflavones and their metabolites. J. Steroid Biochem. Mol. Biol. 112(1-3), 87-94 (2008).
4. Takeuchi S, Takahashi T, Sawada Y, Iida M, Matsuda T, Kojima H. Comparative study on the nuclear hormone receptor activity of various phytochemicals and their metabolites by reporter gene assays using Chinese hamster ovary cells. Biol. Pharm. Bull. 32(2), 195-202 (2009).
5. Muthyala RS, Ju YH, Sheng S et al. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R-and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg. Med. Chem. 12(6), 1559-1567 (2004).
6. Perou CM, Sorlie T, Eisen MB et al. Molecular portraits of human breast tumours. Nature 406(6797), 747-752 (2000).
7. Sorlie T, Perou CM, Tibshirani R et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 98(19), 10869-10874 (2001).
8. Wood LD, Parsons DW, Jones S et al. The genomic landscapes of human breast and colorectal cancers. Science 318(5853), 1108-1113 (2007).
9. Bosviel R, Garcia S, Lavediaux G et al. BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls. Cancer Epidemiol. 36(3), e177-e182 (2012).
10. Adjakly M, Bosviel R, Rabiau N et al. DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines. Epigenomics 3(6), 795-803 (2011).
11. Kurdistani SK. Histone modifications as markers of cancer prognosis: A cellular view. Br. J. Cancer 97(1), 1-5 (2007).
12. Santos-Rosa H, Caldas C. Chromatin modifier enzymes, the histone code and cancer. Eur. J. Cancer 41(16), 2381-2402 (2005).
13. Kouzarides T. Chromatin modifications and their function. Cell 128(4), 693-705 (2007).
14. Jenuwein T, Allis CD. Translating the histone code. Science 293(5532), 1074-1080 (2001).
15. Bernstein BE, Kamal M, Lindblad-Toh K et al. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120(2), 169-181 (2005).
16. Pokholok DK, Harbison CT, Levine S et al. Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 122(4), 517-527 (2005).
17. Schneider R, Bannister AJ, Myers FA, Thorne AW, Crane-Robinson C, Kouzarides T. Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat. Cell Biol. 6(1), 73-77 (2004).
18. Yoo KH, Hennighausen L. EZH2 methyltransferase and H3K27 methylation in breast cancer. Int. J. Biol. Sci. 8(1), 59-65 (2012).
19. Tang Y, Zhao W, Chen Y, Zhao Y, Gu W. Acetylation is indispensable for p53 activation. Cell 133(4), 612-626 (2008).
20. Peterson CL, Laniel MA. Histones and histone modifications. Curr. Biol. 14(14), R546-551 (2004).
21. Long W, Foulds CE, Qin J et al. ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion. J. Clin. Invest. 122(5), 1869-1880 (2012).
22. Esteller M, Silva JM, Dominguez G et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl Cancer Inst. 92(7), 564-569 (2000).
23. Satih S, Rabiau N, Bignon YJ, Bernard-Gallon DJ. Soy phytoestrogens and breast cancer chemoprevention: molecular mechanisms. Curr. Nutr. Food Sci. 4, 259-264 (2008).
24. Cailleau R, Young R, Olive M, Reeves WJ Jr. Breast tumor cell lines from pleural effusions. J. Natl Cancer Inst. 53(3), 661-674 (1974).
25. Soule HD, Vazguez J, Long A, Albert S, Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl Cancer Inst. 51(5), 1409-1416 (1973).
26. Vissac-Sabatier C, Bignon YJ, Bernard-Gallon DJ. Effects of the phytoestrogens genistein and daidzein on BRCA2 tumor suppressor gene expression in breast cell lines. Nutr. Cancer 45(2), 247-255 (2003).
27. Yerbes R, Lopez-Rivas A. Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAIL. Invest. New Drugs 30(2), 541-547 (2012).
28. Pasqualini JR. The selective estrogen enzyme modulators in breast cancer: A review. Biochim. Biophys. Acta 1654(2), 123-143 (2004).
29. Hedlund TE, Johannes WU, Miller GJ. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro. Prostate 54(1), 68-78 (2003).
30. Jackson RL, Greiwe JS, Desai PB, Schwen RJ. Single-dose and steady-state pharmacokinetic studies of S-equol, a potent nonhormonal, estrogen receptor beta-agonist being developed for the treatment of menopausal symptoms. Menopause 18(2), 185-193 (2011).
31. Plomley JB, Jackson RL, Schwen RJ, Greiwe JS. Development of chiral liquid chromatography-tandem mass spectrometry isotope dilution methods for the determination of unconjugated and total S-equol in human plasma and urine. J. Pharm. Biomed. Anal. 55(1), 125-134 (2011).
32. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 8(4), 286-298 (2007).
33. Volkel P, Angrand PO. The control of histone lysine methylation in epigenetic regulation. Biochimie 89(1), 1-20 (2007).
34. Wolff MS, Weston A. Breast cancer risk and environmental exposures. Environ. Health Perspect. 105(Suppl. 4), 891-896 (1997).
35. Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br. J. Cancer 98(1), 9-14 (2008).
36. Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J. Natl Cancer Inst. 98(7), 459-471 (2006).
37. Keinan-Boker L, van Der Schouw YT, Grobbee DE, Peeters PH. Dietary phytoestrogens and breast cancer risk. Am. J. Clin. Nutr. 79(2), 282-288 (2004).
38. Kondo Y, Shen L, Cheng AS et al. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat. Genet. 40(6), 741-750 (2008).
39. Bosviel R, Dumollard E, Dechelotte P, Bignon YJ, Bernard-Gallon D. Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer? OMICS 16(5), 235-244 (2012).
40. King-Batoon A, Leszczynska JM, Klein CB. Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ. Mol. Mutagen. 49(1), 36-45 (2008).
41. Bosviel R, Durif J, Dechelotte P, Bignon YJ, Bernard-Gallon D. Epigenetic modulation of BRCA1 and BRCA2 gene expression by equol in breast cancer cell lines. Br. J. Nutr. 108(7), 1187-1193 (2012).
42. Fang M, Chen D, Yang CS. Dietary polyphenols may affect DNA methylation. J. Nutr. 137(Suppl. 1), S223-S228 (2007).
43. Hong T, Nakagawa T, Pan W et al. Isoflavones stimulate estrogen receptor-mediated core histone acetylation. Biochem. Biophys. Res. Commun. 317(1), 259-264 (2004).
44. Zwart W, Theodorou V, Kok M, Canisius S, Linn S, Carroll JS. Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer. EMBO J. 30(23), 4764-4776 (2011).
45. Nadal-Serrano M, Sastre-Serra J, Pons DG, Miro AM, Oliver J, Roca P. The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17beta-estradiol. J. Cell Biochem. 113(10), 3178-3185 (2012).
46. Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson JA. Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc. Natl Acad. Sci. USA 101(6), 1566-1571 (2004).